Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Samalin

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Scientific Reports|April 29, 2026
Circulating tumor cell-derived lines exhibit an amoeboid mode of migrationGuillaume Belthier, Veronika Te Boekhorst, Zeinab Homayed, et al.
The Oncologist|June 2, 2019
Characteristics of <i>BRAF</i><sup></sup> Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 PatientsChristelle de la Fouchardière, Romain Cohen, David Malka, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 30, 2022
SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancerEmeric Boisteau, Eric François, Thomas Aparicio, et al.
Cancers|January 8, 2023
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry StudyKarl Bordeau, Morgan Michalet, Aïcha Keskes, et al.
Nature Communications|March 20, 2021
FTO-mediated cytoplasmic m<sup>6</sup>A<sub>m</sub> demethylation adjusts stem-like properties in colorectal cancer cellSébastien Relier, Julie Ripoll, Hélène Guillorit, et al.
Oncology|January 20, 2016
First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease ControlNuria Kotecki, Sandrine Hiret, Pierre-Luc Etienne, et al.
NPJ Precision Oncology|June 26, 2026
Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary studyAlix Mérigout, Emmanuelle Samalin, Anthony Turpin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 30, 2022
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trialClélia Coutzac, Frederic Bibeau, Meher Ben Abdelghani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2026
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEPChristelle de la Fouchardière, Aziz Zaanan, Aymeric de Montfort, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 4, 2019
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significanceSimon Pernot, Magali Terme, Nina Radosevic-Robin, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Scientific Reports|April 29, 2026
Circulating tumor cell-derived lines exhibit an amoeboid mode of migrationGuillaume Belthier, Veronika Te Boekhorst, Zeinab Homayed, et al.
The Oncologist|June 2, 2019
Characteristics of <i>BRAF</i><sup></sup> Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 PatientsChristelle de la Fouchardière, Romain Cohen, David Malka, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 30, 2022
SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancerEmeric Boisteau, Eric François, Thomas Aparicio, et al.
Cancers|January 8, 2023
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry StudyKarl Bordeau, Morgan Michalet, Aïcha Keskes, et al.
Nature Communications|March 20, 2021
FTO-mediated cytoplasmic m<sup>6</sup>A<sub>m</sub> demethylation adjusts stem-like properties in colorectal cancer cellSébastien Relier, Julie Ripoll, Hélène Guillorit, et al.
Oncology|January 20, 2016
First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease ControlNuria Kotecki, Sandrine Hiret, Pierre-Luc Etienne, et al.
NPJ Precision Oncology|June 26, 2026
Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary studyAlix Mérigout, Emmanuelle Samalin, Anthony Turpin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 30, 2022
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trialClélia Coutzac, Frederic Bibeau, Meher Ben Abdelghani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2026
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEPChristelle de la Fouchardière, Aziz Zaanan, Aymeric de Montfort, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 4, 2019
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significanceSimon Pernot, Magali Terme, Nina Radosevic-Robin, et al.
Pageof 7